Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in healthy adults in South Africa

BACKGROUND: The efficacy of BCG may be enhanced by heterologous vaccination strategies that boost the BCG-primed immune response. One leading booster vaccine, MVA85A, has shown promising safety and immunogenicity in UK human trials. We investigated the safety and immunogenicity of MVA85A in mycobact...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Hawkridge, Tony, Scriba, Thomas J., Gelderbloem, Sebastian, Smit, Erica, Tameris, Michele, Moyo, Sizulu, Lang, Trudie, Veldsman, Ashley, Hatherill, Mark, van der Merwe, Linda, Fletcher, Helen A, Mahomed, Hassan, Hill, Adrian V.S., Hanekom, Willem A., Hussey, Gregory D., McShane, Helen
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2822902/
https://ncbi.nlm.nih.gov/pubmed/18582195
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/590185
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires